ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.369,03
-0,25%
S&P 500
5.486,36
1,01%
US Dollar vs BRL
5,4258
1,41%
Bitcoin
66.810,93
0,26%
Brent Oil
83,97
2,25%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Universe Pharmaceuticals Inc (UPC)

  7. Universe Pharmaceuticals Inc (UPC) Notícias

UPC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:UPC
DataHoraFonteTítuloCódigoCompanhia
10/06/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UPCUniverse Pharmaceuticals Inc
14/05/202417:06Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:UPCUniverse Pharmaceuticals Inc
07/02/202410:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202418:30PR Newswire (US)Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
30/01/202414:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:UPCUniverse Pharmaceuticals Inc
04/08/202309:30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesNASDAQ:UPCUniverse Pharmaceuticals Inc
27/07/202311:15GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
24/05/202317:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:UPCUniverse Pharmaceuticals Inc
07/03/202310:00GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
14/02/202316:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:UPCUniverse Pharmaceuticals Inc
10/02/202318:58Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:UPCUniverse Pharmaceuticals Inc
21/12/202210:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19NASDAQ:UPCUniverse Pharmaceuticals Inc
14/11/202210:00GlobeNewswire Inc.Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:UPCUniverse Pharmaceuticals Inc
27/10/202217:11Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:UPCUniverse Pharmaceuticals Inc
16/08/202209:00PR Newswire (US)Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022NASDAQ:UPCUniverse Pharmaceuticals Inc
30/03/202209:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce PlatformsNASDAQ:UPCUniverse Pharmaceuticals Inc
22/03/202209:00GlobeNewswire Inc.Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research CenterNASDAQ:UPCUniverse Pharmaceuticals Inc
11/02/202210:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:UPCUniverse Pharmaceuticals Inc
31/01/202210:00GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial ResultsNASDAQ:UPCUniverse Pharmaceuticals Inc
04/01/202210:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
29/12/202110:00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
15/12/202118:30GlobeNewswire Inc.Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating OfficerNASDAQ:UPCUniverse Pharmaceuticals Inc
13/12/202110:30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
02/08/202109:00GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021NASDAQ:UPCUniverse Pharmaceuticals Inc
30/07/202109:00GlobeNewswire Inc.Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021NASDAQ:UPCUniverse Pharmaceuticals Inc
26/07/202109:00GlobeNewswire Inc.Universe Pharmaceuticals INC Hosts Reception for Member of Chinese Academy of Engineering and Expert Group from Tianjin University of Traditional Chinese MedicineNASDAQ:UPCUniverse Pharmaceuticals Inc
25/05/202109:00GlobeNewswire Inc.Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.NASDAQ:UPCUniverse Pharmaceuticals Inc
12/05/202109:00GlobeNewswire Inc.Universe Pharmaceuticals INC Attends West Lake Forum and Exhibits Upgraded ProductsNASDAQ:UPCUniverse Pharmaceuticals Inc
31/03/202117:30GlobeNewswire Inc.Univest Securities, LLC Announces the Full Exercise of Underwriter’s Over-Allotment Option for its Client Universe Pharmace...NASDAQ:UPCUniverse Pharmaceuticals Inc
31/03/202117:15GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Full Exercise of Underwriter’s Over-Allotment Option in the Public OfferingNASDAQ:UPCUniverse Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:UPC

Seu Histórico Recente

LSE
AE99
Citi Fun 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados